The activation of CAR inhibits leukocyte adhesion to dysfunctional endothelial cells.[16] Moreover, CAR activation benefits inflammatory bowel disease by reducing damage and promoting intestinal mucosal repair.[17] Nevertheless, whether and how CAR participates in the pathological process of endotoxin‐induced liver injury remains largely unknown. The gene discussed is NR1I3; the disease is inflammatory bowel disease.